Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +16.4% | +46.7% | 3 / 3 | +48.4% | -1.33 pp | -0.48 pp | +4.1% | 0.00 | 13.80 | 152 | +48,4% | 2,7 | +16,4% | 13.80 | 11.65 | +18,4% |
| Pts | 0 | 12 | 12 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.700 (close price on 2026-10-15)EPS (TTM): 485,5
Financial charts
1.Revenue & growth
VND bn152Q2/26
1.Revenue & growth
VND bn152Q2/26
2.Profit & growth
VND bn2,68Q2/26
3.Profit mix (Penman)
VND bn8,62Q2/26
4.Margins & cost structure
%2.8%Q2/26
5.Returns & cash cycle
% · days3.9%Q2/26
6.Earnings quality & cash
VND bn0,04Q2/26
7.Asset structure
VND bn288Q2/26
8.Funding & debt health
VND bn · times288Q2/26
9.Revenue backlog
VND bn0,83Q2/26
10.Valuation
times · %13,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %189Q2/26
Adjusted EPS growth, latest quarter
16.4%
Average adjusted EPS growth, 3 quarters
9.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26